Skip to main content

EU EFRE - Further development and optimization of ultrapure water evaporation plants

Goal

The aim of the project is the further development and optimization of ultrapure water systems that are required for applications in the pharmaceutical industry. This includes a holistic view of the system, which consists of up to ten interconnected evaporators. The individual components, i.e. the individual tube bundle evaporators, are also examined in detail and optimized for use with ultrapure water.

As the previous design is based on empirical values, an explicit transfer of knowledge from the university to the regional economy can take place here. Ultrapure water systems produce so-called WFI water, which is used, for example, to produce injection solutions. Such plants are directly integrated into the pharmaceutical manufacturing process and are also considered high technology in this area. The high purity of the WFI water is achieved in a final manufacturing step by evaporating and re-condensing the entire quantity of water.

The questions to be answered as part of the project are aimed at increasing the efficiency of ultrapure water systems in the areas of energy transfer, component size and production costs. In addition, the overall system is being examined in terms of system operating status (pressure, temperature, throughput) and system design.

In addition to modern analysis tools (flow sheeting) for assessing the overall system, detailed observations are made on individual assemblies with the aid of modern measurement and simulation tools.

Partner

DEWA Engineering und Anlagenbau GmbH, Vienenburg
TU Clausthal, Institute for Chemical Process Engineering

Contact us

Dipl.-Ing. W. Kerschbaumer

Financing

EU EFRE 1005.174 (2005-2008)